Observational Substance Use Epidemiology: A case study

Similar documents
Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD

Changes in injecting practices associated with the use of a medically supervised safer injection facility

ETHNO-EPIDEMIOLOGICAL APPROACHES TO UNDERSTANDING DRUG-RELATED RELATED HARM

15 Years of Supervised Drug Consumption Vancouver, Canada

Factors Associated with Syringe Sharing Among Users of a Medically Supervised Safer Injecting Facility

MONTANER S AND KERR S STRAW MEN EXPOSED

Supervised Injection Services: Evidence and Practice

Vancouver s Pilot Medically Supervised Safer Injecting Facility Insite

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria

Prevalence and correlates of hepatitis C infection among users of North America s first medically supervised safer injection facility

Burden of HIV Infection Among Aboriginal Injection Drug Users in Vancouver, British Columbia

Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

Boston's New Harm Reduction Program for Opioid Users Forges New Ground. July 28, 2016

Supportive Place for Observation and Treatment (SPOT): New Harm Reduction Programming at BHCHP

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Safeworks and Harm Reduction

Margot Kuo, Despina Tzemis, Ellison Richmond, Jane Buxton. CPHA 2012 June 12, 2012 Edmonton, AB

REPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES)

How Can Injectable Hydromorphone and Pharmaceutical-Grade Heroin be Used to Treat Opioid Use Disorder?

Determinants of Cutaneous Injection-Related Infections Among Injection Drug Users at an Emergency Department

References. Andresen, M. A., & Jozaghi, E. (2012). The point of diminishing returns: an examination of

North American Opiate Medication Initiative (NAOMI)

Rapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic

Research funded by a SSHRC Standard Grant, two SSHRC Institutional Grants, an SFU President s Research Grant, and an SFU Endowed Research Fellowship.

Treatment as Prevention:

Ehsan Jozaghi. School of Criminology Simon Fraser University

Public Health Association of British Columbia

Questions & Answers. What are the risks associated with consumption drug use?

NIH Public Access Author Manuscript Am J Public Health. Author manuscript; available in PMC 2011 August 1.

STAFF REPORT ACTION REQUIRED. Supervised Injection Services in Toronto SUMMARY. Date: June 21, Board of Health. To: Medical Officer of Health

Australian Injecting and Illicit Drug Users League. Policy Position Paper 8 Retractable Syringes

Prevalence of cannabis-impaired driving and crash risk

Question. Lillian Sung MD, PhD. The Hospital for Sick Children. February 10, 2017

Supervised Consumption Facilities Review of the Evidence SHARON LARSON, PHD NORMA PADRON, PHD JENNIFER MASON TYLER BOGACZYK

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Building and enhancing capacity for HCV prevention; BC case scenario

Christiana Care hosts workshop to spread what works in addiction care

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies

TWO-THIRDS OF CANADIANS SUPPORT LEGALIZING MARIJUANA: BUT ONLY IF THEY DON T SEE IT

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

Epidemiologic Methods and Counting Infections: The Basics of Surveillance

Scotland s national naloxone programme (NNP): what have we learned?

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

The Pillars Approach: A Case Study

NEW JERSEY: SUPPORT FOR LEGAL WEED STAYS HIGH

BENZODIAZEPINE DEPENDENCE AMONG MULTIDRUG USERS IN THE CLUB SCENE. Steven P. Kurtz and Mance E. Buttram

March 16, Ms. Nancy Martins 10 th Bloor, West Tower, City Hall 100 queen Street West Toronto, ON M5H 2N2

Ministry of Health and Long-Term Care Overdose Prevention Sites: User Guide for Applicants

Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation.

Clinical Study Design: From Pilot to Randomized Controlled Trials

Confounding in influenza VE studies in seniors, and possible solutions

who use drugs in order to assist them in reducing harm while in the cycle of addiction

Reducing opioid overdose mortality: role of communityadministered

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

Chiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT

Risk Line-Up Game with Harm Reduction

Psychology 205, Revelle, Fall 2014 Research Methods in Psychology Mid-Term. Name:

Harm Reduction and Research: Evaluation of the Supportive Place for Observation and Treatment (SPOT)

What Are Your Odds? : An Interactive Web Application to Visualize Health Outcomes

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

VCH Overdose Surveillance Updates

11 questions to help you make sense of a case control study

Bias and confounding. Mads Kamper-Jørgensen, associate professor, Section of Social Medicine

From Grief to Action: When Addiction Hits Home

Part One of a Two Part Series: Harm Reduction and Substance Use- What You Need To Know

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

Harm Reduction s Role in Helping People Return Safely from Prison and Jail. Scott Burris Professor of Law and Public Health

Chi-Square Goodness-of-Fit Test

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

What is harm reduction?

Challenges of Observational and Retrospective Studies

BIOSTATISTICAL METHODS

Incorporating Clinical Information into the Label

How to use this appraisal tool: Three broad issues need to be considered when appraising a case control study:

Historical Perspectives

What is injection drug use?

The Cedar Project Exploring the role of residential transience in HIV vulnerability among young Aboriginal people who use illicit drugs.

Single-Use Safety Syringes

CRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness. 11 questions to help you make sense of case control study

Psychology of Dysfunctional Behaviour RESEARCH METHODS

CHAPTER 5: PRODUCING DATA

Harm Reduction in the Hospital: Preventing AMA Discharges and ED Bounce Backs

Confounding and Bias

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY

The Opioid Overdose Crisis: Role of the TB Physician

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Substance Prevention

Kelty Mental Health Resource Centre, Pinwheel Education Series: Youth and the Opioid Crisis

A Differential Item Functioning (DIF) Analysis of the Self-Report Psychopathy Scale. Craig Nathanson and Delroy L. Paulhus

Evidence Review: Communicable Disease (Harm Reduction)

observational studies Descriptive studies

The Practice of Statistics 1 Week 2: Relationships and Data Collection

EXECUTIVE SUMMARY HIGHLIGHTS

Supervised Consumption: A Report to the Community of Medicine Hat

Smoking Cessation In Patients With Substance Use Disorders: The Vancouver Coastal Health Tobacco Dependence Clinic

Transcription:

Observational Substance Use Epidemiology: A case study Evan Wood MD, PhD, FRCPC, ABAM Dip. FASAM Director, BC Centre on Substance Use Professor of Medicine and Canada Research Chair University of British Columbia Research in Addiction Medicine Scholars (RAMS) webinar Monday, January 22, 2018

Core Functions

Outline 1. Basic concepts in observational epidemiology 2. A case study 3. Some notes on publications Please put down phones and other distractions as this will be very interactive!

What is the definition of Epidemiology?

Definition of Epidemiology: The study of the distribution and determinants of disease frequency in human populations (usually through the interpretation of statistical associations)

What 4 things can explain a statistical association?

1. Chance: We assess chance by The p-value. You often get a statistic such as an odds ratio that reports the strength of the association between exposure and disease In medicine, we generally allow a 5% probability that our findings are due to chance

2. Bias Any systematic error in an epidemiologic study that results in an incorrect estimate of the association between exposure and risk of disease

3. Confounding A mixing of effects between the exposure of interest, the disease, and a third factor that is associated with the exposure and independently affects the risk of developing the disease Coffee E Smoking E Cancer

4. Causation Smoking E Cancer

For bonus marks: What are some types of confounding?

Types of confounding: Pure confounding : estimate goes from 6.0 (95% CI: 3.0 9.0) in unadjusted analyses to 1.0 (9%% CI: 1.0 1.0) after adjustment

Types of confounding: What if estimate goes from 6.0 (95% CI: 3.0 9.0) in unadjusted analyses to 3.0 (9%% CI: 1.5 4.5) after adjustment?

Types of confounding: If estimate goes from 6.0 (95% CI: 3.0 9.0) in unadjusted analyses to 3.0 (9%% CI: 1.5 4.5) after adjustment this could be Partial confounding (e.g. gender) or Residual confounding (e.g. smoking)

What are observational studies?

What are observational studies? An observational study seeks to draw statistical inferences from a sample to a population where the independent variable(s) is not under the control of the researcher - From a sample to a population (? Generalizability) - Natural history rather than active manipulation (e.g. not an RCT)

Why do we do observational studies?

Why do we do observational studies? When not ethical to control a variable (e.g. with something helpful or offer something dangerous), limited resources, secondary data analysis For instance, is it ethical to randomize individuals to accessing a supervised injecting facility or not?

What is the classic observational study and what is are the main limitations on doing cohort based research?

What is the classic observational study and what is are the main limitations on doing cohort based research? Classic study would be the cohort study Most common limitation is cost

A Case Study

Potential Impacts of SIF? During a observational study (VIDUS) follow-up, participants were asked if they would use a medically supervised SIF if one were available Those that expressed willingness were compared to those that did not

What type of study is this?

What type of study is this? Cross sectional study

Logistic regression analysis* of factors associated with willingness to attend Safe Injection Facilities were one available. Adjusted 95 % Variable Odds ratio Confidence Interval p-value Hard to get Clean Needles (Yes versus No) 2.07 (1.35 3.17) <0.001 Requiring Help Injecting (Yes versus No) 1.52 (1.01 2.30) 0.045 Heroin use Frequency (> 1 daily Daily versus <1) 1.81 (1.22 2.68) 0.030 Public Injection Drug Use (Yes versus No) 2.00 (1.27 3.16) 0.003 Sex-trade work (Yes versus No) 2.02 (1.31 3.12) 0.001 * Model was adjusted for age, and frequency of cocaine injection. Wood et al. J AIDS [FT] 2003;32(1):2-8.

state-sponsored suicide

SEOSI = Scientific Evaluation of Supervised Injecting Cohort

Wood et al, American Journal of Preventative Medicine, 2005

What type of study is this?

What type of study is this? Prospective observational cohort study

Canadian Medical Association Journal. 2004

What are potential sources of bias in this study design and how might you assess for bias?

What are potential sources of bias and how might you assess for bias? Bias on the part of the person counting public drug use and discarded needles Ideally, secondary data sets could be used to confirm observations (could not blind)

When the number of syringes discarded in the neighbourhood s 6 outdoor safe disposal boxes were examined, the mean number per box per week was significantly higher before than after the safer injecting facility opened (30.9 v. 9.4; p < 0.001).

Kerr et al, The Lancet, 2005

What type of study is this?

Kerr et al, The Lancet, 2005

What might explain this association?

How might you ensure your study sample is representative?

If a study followed a random sample of Insite users forward to see who got into detoxification programs and you did an analysis of time to first enrollment what type of study design would this be?

In epidemiology, time to event (e.g. death) are often referred to as survival analyses

Marshall et al, Lancet, 2011

Methods Location of death estimated using six-digit postal code Geocoding: ArcGIS using the Statistics Canada Postal Code Conversion File Area of interest: all blocks within 500 metres of the SIF Quasi-control: blocks >500m from the SIF Outcome: rate difference in OD mortality between the pre-sif (Jan 1, 2001 Sep 20, 2003) and post-sif (Sep 21, 2003 Dec 31, 2005) periods

Results Fatal OD s in Vancouver between Jan 1, 2001 & Dec 31, 2005 SIF Population Size 0 1-100 101-200 201-300 301-400 401-500 >500

Overdose deaths declined by 35% in the area around Insite Marshall et al, Lancet, 2011

The Institute is charged with creating and strengthening international laws that hold drug users and dealers criminally accountable for their actions. The institute supports efforts to vigorously oppose policies based on the concept of harm reduction. (see: http://www.dfaf.org/globaldrugpolicy.php)

National Post, May 29, 2007

A couple of thoughts on publication Have healthy writing practices Consider all journal sections and range of journals Be open to concise reports rather than full length articles Be aware that journals like review articles and when you cite articles from their journal Don t be deterred by rejection When addressing reviews, the reviewer is always right Consider an appeal but don t waste time You will learn more about epidemiology by doing than by just studying the concepts There are ethical and career implications of not being productive with peer-reviewed publication

Questions & Discussion

Acknowledgements Colleagues, fellows, students and staff at BCCSU Research participants evanw@cfenet.ubc.ca